1. Home
  2. PMCB vs SOPA Comparison

PMCB vs SOPA Comparison

Compare PMCB & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • SOPA
  • Stock Information
  • Founded
  • PMCB 1996
  • SOPA 2018
  • Country
  • PMCB United States
  • SOPA Singapore
  • Employees
  • PMCB N/A
  • SOPA N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • SOPA EDP Services
  • Sector
  • PMCB Health Care
  • SOPA Technology
  • Exchange
  • PMCB Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • PMCB 6.6M
  • SOPA 7.4M
  • IPO Year
  • PMCB N/A
  • SOPA 2021
  • Fundamental
  • Price
  • PMCB $0.93
  • SOPA $1.19
  • Analyst Decision
  • PMCB
  • SOPA Strong Buy
  • Analyst Count
  • PMCB 0
  • SOPA 1
  • Target Price
  • PMCB N/A
  • SOPA $15.00
  • AVG Volume (30 Days)
  • PMCB 106.5K
  • SOPA 81.7K
  • Earning Date
  • PMCB 09-15-2025
  • SOPA 11-14-2025
  • Dividend Yield
  • PMCB N/A
  • SOPA N/A
  • EPS Growth
  • PMCB N/A
  • SOPA N/A
  • EPS
  • PMCB 0.01
  • SOPA N/A
  • Revenue
  • PMCB N/A
  • SOPA $7,522,939.00
  • Revenue This Year
  • PMCB N/A
  • SOPA N/A
  • Revenue Next Year
  • PMCB N/A
  • SOPA $45.16
  • P/E Ratio
  • PMCB $160.47
  • SOPA N/A
  • Revenue Growth
  • PMCB N/A
  • SOPA 0.31
  • 52 Week Low
  • PMCB $0.80
  • SOPA $0.64
  • 52 Week High
  • PMCB $2.42
  • SOPA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 44.27
  • SOPA 44.93
  • Support Level
  • PMCB $1.00
  • SOPA $1.18
  • Resistance Level
  • PMCB $1.08
  • SOPA $1.24
  • Average True Range (ATR)
  • PMCB 0.08
  • SOPA 0.07
  • MACD
  • PMCB -0.00
  • SOPA -0.01
  • Stochastic Oscillator
  • PMCB 2.95
  • SOPA 20.83

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: